Regeneron, MedImmune Enter Licensing Agreement

News   Apr 07, 2016

 
Regeneron, MedImmune Enter Licensing Agreement
 
 
 

RELATED ARTICLES

Deficiency of Innate Immune Adaptor TRIF Linked to Neurodegeneration

News

Research has revealed that deficiency of the innate immune adaptor TRIF, which is essential for certain Toll-like receptor signaling cascades, significantly shortened survival time of ALS mice.

READ MORE

‘Bad’ Antibodies Provide Crucial Protection Against Invading Microbes

News

In a world first, scientists have revealed how a population of 'bad' antibodies in the immune system - which are usually 'silenced' because they can harm the body - can provide crucial protection against invading microbes.

READ MORE

IONTAS and IGEM Therapeutics Collaborate to Identify Novel IgE Antibodies

News

The project will add to IGEM’s pipeline of drugs and expand upon IGEM-F, an IgE targeting ovarian and other cancers, currently in a Phase 1/2a study.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE